Libra Infusions Limited

DSE:LIBRAINFU Stock Report

Market Cap: ৳1.7b

Libra Infusions Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Roushon Alam

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure3yrs
Board average tenure3yrs

Recent management updates

Recent updates

CEO

Roushon Alam

no data

Tenure

Dr. Roushon Alam serves as the Chief Executive Officer, Managing Director and Director of Libra Infusions Ltd.

Leadership Team

NamePositionTenureCompensationOwnership
Roushon Alam
CEO, MD & Directorno datano datano data
A. N. Mainuddin
Chief Financial Officerno datano datano data
Md. Hasan
Head of Internal Auditorno datano datano data
K. Kawsar Ali
Nominee Director3yrsno datano data
Kutub Uddin
Head of Internal Auditors3yrsno datano data
Md. Shafiqul Bhuyan
Company Secretary3yrsno datano data

3.0yrs

Average Tenure

Experienced Management: LIBRAINFU's management team is considered experienced (3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Roushon Alam
CEO, MD & Directorno datano datano data
K. Kawsar Ali
Nominee Director3yrsno datano data
Ayesha Alam
Chairpersonno datano datano data
Saira Alam
Directorno datano datano data
Monami Alam
Directorno datano datano data
Shefta Alam
Directorno datano datano data
Enamul Kabir
Independent Director3yrsno datano data
N. Chowdhury
Independent Director3yrsno datano data

3.0yrs

Average Tenure

Experienced Board: LIBRAINFU's board of directors are considered experienced (3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 04:00
End of Day Share Price 2025/01/02 00:00
Earnings2019/06/30
Annual Earnings2019/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Libra Infusions Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution